Dr. Guillaume Lessene, Walter and Eliza Hall Institute (IMAGE)
Caption
Dr Guillaume Lessene and his collaborators have tailor-made a new chemical compound that blocks a protein that has been linked to poor responses to treatment in cancer patients.
Credit
Walter and Eliza Hall Institute, Australia
Usage Restrictions
None
License
Licensed content